Characterization of 3ll‐tumor variants generated by in vitro macrophage‐mediated selection
- 15 March 1987
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 39 (3) , 343-352
- https://doi.org/10.1002/ijc.2910390313
Abstract
Following sequential interactions between activated syngeneic Mϕs and 3LL tumor cells, stable Mϕ‐resistant 3LL variants were isolated. Unlike the unselected 3LL cells, these Mϕ‐selected variants were relatively resistant to the cytostatic and cytolytic activity of activated effector Mϕs. Such Mϕ‐resistant 3LL variants evade the Mϕ tumoricidal activity by at least two mechanisms. Firstly, they manifest a reduced susceptibility towards Mϕ‐related cytotoxins such as TNF. Secondly, they actively suppress the cytotoxic potential of Mϕs through secretion of Mϕ‐inhibitory factors. The resistance of the 3LL variants to Mϕ effector cells in vitro was reflected in vivo by a higher tumorigenic and metastatic potential. No strict correlation was found between the NK sensitivity of Mϕ‐resistant and Mϕ‐sensitive 3LL cells and their metastatic ability. Hence, activated tumoricidal Mϕs may play a central role in either the elimination or selection of neoplastic cells.This publication has 27 references indexed in Scilit:
- Recombinant tumor necrosis factor: its effect and its synergism with interferon-γ on a variety of normal and transformed human cell linesEuropean Journal of Cancer and Clinical Oncology, 1986
- T cell-mediated immunity in murine malaria. II. Induction of protective immunity to P. chabaudi by antigen fed macrophages and antigen educated lymphocytesParasite Immunology, 1984
- Heterogeneity of murine mammary adenocarcinoma cell subpopulations.in vitro andin vivo resistance to macrophage cytotoxicity and its association with metastatic capacityInternational Journal of Cancer, 1984
- MHC imbalance and metastatic spread in Lewis lung carcinoma clonesInternational Journal of Cancer, 1983
- Selection of macrophage-resistant progressor tumor variants by the normal host. Requirement for concomitant T cell-mediated immunity.The Journal of Experimental Medicine, 1983
- Cancer metastasis: Organ colonization and the cell-surface properties of mallignant cellsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1982
- Suppression of macrophage oxidative metabolism by products of malignant and nonmalignant cells.The Journal of Experimental Medicine, 1982
- Mechanisms of syngeneic tumor rejection. Susceptibility of host-selected progressor variants to various immunological effector cells.The Journal of Experimental Medicine, 1982
- Tumor cell anti-oxidant defenses. Inhibition of the glutathione redox cycle enhances macrophage-mediated cytolysisThe Journal of Experimental Medicine, 1981
- Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide.The Journal of Experimental Medicine, 1979